查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1912910

自动化磁珠纯化系统市场：全球预测（2026-2032 年），依产能、应用和最终用户划分

Fully Automatic Magnetic Bead Purification System Market by Throughput, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，自动化磁珠纯化系统市场价值将达到 1.8572 亿美元，到 2026 年将成长至 2.0318 亿美元，到 2032 年将达到 3.2091 亿美元，复合年增长率为 8.12%。

主要市场统计数据
基准年 2025 1.8572亿美元
预计年份：2026年 2.0318亿美元
预测年份：2032年 3.2091亿美元
复合年增长率 (%) 8.12%

磁珠纯化自动化如何透过在科研和临床环境中提供一致性、可追溯性和灵活集成，从而改变实验室工作流程

全自动轮胎边缘纯化系统将磁珠化学、机器人技术和流体控制相结合，实现了核酸和蛋白质纯化的自动化，正迅速成为现代分子工作流程的核心组成部分。这些平台透过可程式设计程式取代重复的手动操作，提高了实验的一致性，减少了人工操作时间，并提升了科学研究和临床应用的通量。因此，实验室可以将技术人员重新部署到分析和结果解读工作中，同时减少手动移液操作带来的变异性。

技术、操作和监管因素正在汇聚，重新定义自动化磁珠纯化系统作为实现标准化和审核的实验室工作流程的策略基础的作用。

随着技术、操作和监管因素的融合，全自动磁珠纯化技术领域正经历变革性的转变，重新定义了样品製备的预期。在技​​术层面，磁珠化学的成熟，以及液体处理精度和磁模组设计的改进，拓展了可可靠处理的基质和分析物范围。因此，仪器不再是小众的自动化工具，而是高效能定序中心、临床诊断实验室和工业生物加工流程的基础组成部分。

2025年关税调整如何推动自动化平台供应链韧性策略，并企业发展製造商的采购週期

2025年美国关税政策的调整为自动化轮胎边缘纯化系统供应链中的相关人员带来了新的成本和营运复杂性。进口设备零件和某些试剂关税的提高迫使采购团队重新评估供应商关係、零件筹资策略以及总到岸成本。为此，自动化平台製造商正在加快双源采购的步伐，并选择性地转移关键生产流程，以降低关税相关成本波动带来的风险。

在实验室自动化领域，容量等级、最终使用者需求和特定应用需求如何共同决定产品差异化、采购优先顺序和供应商定位？

这种细分方法为理解不同实验室环境和工作流程中的需求趋势和产品适用性提供了切实可行的观点。基于通量视角，设备选择的优先顺序差异显着。高通量环境强调週期时间、试剂节省以及与机器人样品处理的无缝整合。中等通量环境重视通讯协定的柔软性和平台重新配置的便利性，而低通量环境则强调面积、操作简便以及耗材使用成本低。这些差异导致供应商在产品开发重点和服务模式上有所不同，以因应不同的应用情境。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势，透过不同的监管环境、支持期望和製造重点，正在塑造供应商的策略。

区域趋势正在以不同的方式影响美洲、欧洲、中东和非洲以及亚太地区的市场采用模式，并塑造供应商的策略。在美洲，大型实验室、临床检测中心和合约检测机构的需求驱动着市场，这些机构优先考虑整合工作流程和快速检测结果交付。此外，对配套服务和在地化支援网路的需求也很强劲，这促使供应商投资建造区域服务中心和培训计画。同时，监管预期和报销环境也在影响哪些诊断应用程式能够最快被采用。

为什么技术模组化、整合服务模式和透明的营运承诺决定了供应商的竞争力以及与客户的长期伙伴关係？

竞争优势取决于技术差异化、卓越服务以及在客户环境中展现营运价值的能力。领先的供应商正在投资模组化平台架构，以支援多种化学方法和通讯协定库，使客户能够将工作流程整合到单一自动化平台上。这种架构的柔软性降低了培训负担，并加速了其在从诊断测试到高效能筛检等各种应用领域的普及。

供应商应专注于模组化产品设计、供应链弹性以及以结果为导向的服务，以确保产品在研究和临床试验领域的应用。

为了满足研发和临床环境中对自动化纯化日益增长的依赖，产业领导者应优先考虑能够协调产品开发、供应链稳定性和以客户为中心的服务模式的策略。首先，应投资于模组化平台设计，该设计支援多种磁珠化学性质、可变平台配置和软体驱动的通讯协定库，从而能够在单一仪器上检验多种应用场景。这种方法能够加速不同终端使用者对自动化纯化技术的接受度，并降低客户生命週期内的培训和检验成本。

我们采用严谨的混合方法研究方法，结合一手访谈、技术文献综述和供应链分析，以确保为实验室自动化利害关係人提供检验且经过验证的见解。

支撑这些发现的研究结合了对核酸和蛋白质纯化自动化相关最新技术文献和监管指南的系统性回顾，以及对实验室主任、采购人员和自动化工程师的访谈。主要资料收集着重于从学术机构到商业临床检查室等各类终端使用者的工作流程偏好、验证挑战和服务期望。受访者的选择旨在涵盖地理多样性和不同的能力水平，从而确保研究结果能够反映集中式和分散式检查环境中的实际操作情况。

本文探讨了自动化、供应链弹性以及协同验证将如何决定未来检查室工作流程中的应用管道和供应商差异化。

总而言之，全自动磁珠纯化系统正从专用自动化设备转型为支援高品质、可重复分子工作流程的基础检查室基础设施。磁珠化学、液体处理精度和软体整合的技术进步正在拓展其应用范围，而营运和监管压力则推动了对检验和审核系统的需求。同时，关税变动等外部因素也凸显了供应链韧性和透明成本结构的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依处理能力分類的自动化磁珠纯化系统市场

  • 高处理能力
  • 低处理能力
  • 中等处理能力

9. 按应用分類的自动化磁珠纯化系统市场

  • 诊断测试
    • 癌症标记检测
    • 遗传疾病筛检
    • 传染病检查
  • 药物发现
    • 生物标记发现
    • 高效能筛检
    • 铅识别
  • 基因组学
    • RNA定序
    • 目标序列
    • 全基因组定序
  • 蛋白质体学
    • 质谱分析
    • 蛋白质晶片
    • 蛋白质印迹法

第十章 依最终用户分類的自动化磁珠纯化系统市场

  • 学术研究机构
  • 临床检查室
  • CRO（受託研究机构）
  • 製药和生物技术公司

第十一章 区域性自动化磁珠纯化系统市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章 自动化磁珠纯化系统市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 各国自动化磁珠纯化系统市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章美国自动化磁珠纯化系统市场

17. 中国自动化磁珠纯化系统市场

第十六章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Hamilton Company
  • MGI Tech Co., Ltd.
  • Omega Bio-tek, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Roche Diagnostics International AG.
  • Tecan Group AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-AE420CB13B17

The Fully Automatic Magnetic Bead Purification System Market was valued at USD 185.72 million in 2025 and is projected to grow to USD 203.18 million in 2026, with a CAGR of 8.12%, reaching USD 320.91 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 185.72 million
Estimated Year [2026] USD 203.18 million
Forecast Year [2032] USD 320.91 million
CAGR (%) 8.12%

How automation in magnetic bead purification is reshaping laboratory workflows by delivering consistency, traceability, and flexible integration across research and clinical environments

Fully automatic magnetic bead purification systems have rapidly become central to modern molecular workflows by combining magnetic bead chemistry with robotics and fluidics to automate nucleic acid and protein cleanup. These platforms replace repetitive manual steps with programmable routines that improve consistency, reduce hands-on time, and enable higher throughput in both research and clinical settings. Consequently, laboratories can reallocate technical staff to analytical and interpretive tasks while reducing variability tied to manual pipetting.

Adoption is driven by an expanding range of applications that demand reliable sample preparation, from next-generation sequencing library preparation to high-sensitivity diagnostic assays. Manufacturers have iteratively refined hardware and consumable interfaces to support diverse bead chemistries and sample types, providing modularity for different workflows. At the same time, integration with laboratory information management systems and downstream instruments has strengthened, enabling traceability and facilitating compliance with regulatory and accreditation requirements. These advances set the stage for broader institutional adoption and for workflows that require reproducible, auditable sample preparation across distributed testing sites.

Converging technological, operational, and regulatory forces are redefining the role of automated magnetic bead purification systems as strategic enablers of standardized, auditable laboratory workflows

The landscape of fully automatic magnetic bead purification is undergoing transformative shifts as technological, operational, and regulatory forces converge to redefine expectations for sample preparation. Technologically, the maturation of bead chemistries alongside improvements in liquid handling precision and magnetic module design has expanded the range of matrices and analytes that can be reliably processed. As a result, instruments are no longer niche automation tools but foundational elements of high-throughput sequencing centers, clinical diagnostic labs, and industrial bioprocess pipelines.

Operationally, there is an increasing emphasis on workflow standardization and reproducibility. Laboratories are prioritizing systems that offer validated protocols for common applications such as RNA sequencing, targeted sequencing, and whole genome sequencing, as well as proteomics workflows that interface with mass spectrometry and protein array platforms. This shift is reinforced by the growing need to harmonize procedures across multi-site networks and contract research organizations. Concurrently, manufacturers are enhancing software ecosystems to offer protocol customization, user-access controls, and audit logs to support quality systems.

Regulatory and market pressures are also reshaping product roadmaps. Clinical diagnostics require instruments and consumables that meet stringent validation standards and support rapid assay turnaround without compromising sensitivity. Consequently, companies are investing in designs that minimize cross-contamination risks, simplify decontamination, and enable traceable sample tracking. In parallel, service models have shifted toward outcome-based offerings, with an increased focus on preventive maintenance, on-site validation assistance, and consumable management to guarantee uninterrupted operations. These combined shifts are driving a repositioning of automation providers from hardware vendors to strategic partners focused on enabling end-to-end laboratory value.

How 2025 tariff adjustments have catalyzed supply chain resilience strategies and reshaped sourcing, procurement cycles, and manufacturer footprints for automation platforms

United States tariff policy developments in 2025 have introduced new dimensions of cost and operational complexity for stakeholders in the supply chain of fully automatic magnetic bead purification systems. Increased duties on imported instrument components and certain reagents have prompted procurement teams to re-evaluate supplier relationships, component sourcing strategies, and total landed cost considerations. In response, manufacturers of automation platforms have accelerated dual-sourcing efforts and are selectively relocating critical manufacturing steps to mitigate exposure to tariff-related cost volatility.

The cumulative impact of these tariff changes has also been felt downstream by laboratories that rely on imported consumables and maintenance parts. Procurement cycles are lengthening as lab managers perform more rigorous supplier due diligence and negotiate longer-term supply contracts to secure price stability and inventory buffering. In addition, some organizations are experimenting with inventory rationalization strategies and consignment models to manage cash flow and reduce exposure to episodic price increases. Regulatory compliance and validation obligations further complicate rapid supplier substitutions, encouraging a cautious, staged approach to any change in consumables or service providers.

Despite these pressures, the sector has seen a parallel rise in collaborative sourcing and regional manufacturing partnerships. Technology providers are increasingly offering service bundles that include guaranteed parts availability and transparent cost models to preserve predictable operational budgets. Ultimately, tariff-driven disruption has catalyzed a strategic re-evaluation of supply chain resilience, prompting stakeholders to prioritize supplier diversification, transparent cost structures, and manufacturing footprints aligned with customer geographies and regulatory requirements.

How throughput tiers, end-user requirements, and application-specific demands converge to define product differentiation, procurement priorities, and vendor positioning in laboratory automation

Segmentation provides practical lenses to understand demand dynamics and product fit across different laboratory environments and workflows. Based on throughput considerations, instrument selection priorities vary significantly: high throughput environments prioritize cycle time, reagent conservation, and seamless integration with robotic sample handling, while medium throughput settings value flexibility across protocols and ease of deck reconfiguration, and low throughput sites emphasize footprint, ease of use, and cost-effective consumable usage. These differences drive distinct product development emphases and service models from vendors seeking to address each use case.

Based on end user distinctions, adoption drivers and purchasing pathways diverge. Academic and research institutes typically prioritize protocol versatility and compatibility with cutting-edge applications such as single-cell workflows and custom library preparations. Clinical diagnostics laboratories focus on validated, regulatory-compliant workflows with stringent contamination control and traceability. Contract research organizations value scalability, reproducibility across batches, and vendor support for high-turnaround projects. Pharma and biotechnology companies emphasize robust validation, integration with upstream and downstream process equipment, and long-term service agreements that align with drug development timelines.

Based on application segmentation, platform capabilities must align with specific analytical goals. Diagnostic testing workflows require high sensitivity and contamination mitigation for cancer marker detection, genetic disorder screening, and infectious disease testing. Drug discovery applications demand adaptability for biomarker discovery, high-throughput screening, and lead identification, with an emphasis on throughput and cross-run consistency. Genomics applications such as RNA sequencing, targeted sequencing, and whole genome sequencing necessitate precision in yield and fragment-size recovery, coupled with low sample-to-sample variability. Proteomics workflows, including mass spectrometry, protein arrays, and western blotting, require optimized bead chemistries and sample cleanup protocols that preserve protein integrity and compatibility with downstream detection methods. Recognizing these segmentation-driven priorities enables more targeted product roadmaps and support services.

Regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific are shaping vendor strategies through distinct regulatory landscapes, support expectations, and manufacturing priorities

Regional dynamics are influencing adoption patterns and shaping vendor strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific in distinct ways. In the Americas, demand is driven by large research institutions, clinical reference laboratories, and contract operations that prioritize integrated workflows and rapid assay turnaround. There is also a strong appetite for bundled services and localized support networks, which encourages vendors to invest in regional service centers and training programs. At the same time, regulatory expectations and reimbursement environments influence which diagnostic applications see the fastest adoption.

Europe, the Middle East & Africa present a mosaic of regulatory environments and laboratory capabilities, which increases the importance of flexible validation support and multi-language software interfaces. Laboratories in these regions often emphasize compliance, interoperability with national health systems, and demonstrable contamination control, which shapes procurement criteria. Vendors that can navigate diverse regulatory pathways and provide robust after-sales support gain competitive advantage. Moreover, collaborative research networks in this region are fostering cross-border standardization efforts that benefit from automation-driven reproducibility.

Asia-Pacific exhibits rapid capacity expansion in genomics and clinical diagnostics, supported by sizable investments in sequencing infrastructure and decentralized testing networks. Local manufacturing capabilities and an emphasis on cost-competitive solutions shape vendor strategies, leading many suppliers to pursue regional partnerships and localized production to shorten lead times. Additionally, emerging diagnostic markets in the region are driving demand for compact, user-friendly systems that can operate in both centralized and decentralized laboratory footprints. These regional nuances collectively influence how vendors prioritize product features, service models, and manufacturing investments.

Why technological modularity, integrated service models, and transparent operational commitments determine vendor competitiveness and long-term customer partnerships

Competitive dynamics hinge on a combination of technological differentiation, service excellence, and the ability to demonstrate operational value in customer environments. Leading suppliers are investing in modular platform architectures that support multiple chemistries and protocol libraries, enabling customers to consolidate workflows onto a single automation backbone. This architectural flexibility reduces training overhead and accelerates adoption across diverse applications, from diagnostic testing to high-throughput discovery.

Service and lifecycle support are also central competitive levers. Vendors that provide proactive maintenance, rapid parts availability, and validation assistance strengthen long-term customer relationships. In parallel, partnerships with consumable manufacturers, reagent suppliers, and software integrators enable suppliers to offer cohesive solutions rather than standalone instruments. Strategic collaborations with academic centers and contract research organizations for co-development and protocol optimization further validate technology platforms and create reference use cases that aid commercial adoption.

Finally, transparency in total cost of ownership components-such as consumable consumption rates, scheduled maintenance windows, and software licensing models-has become a decision-making criterion for procurement officers. Manufacturers that couple technical performance with predictable operational models and clear support commitments are better positioned to secure long-term contracts and enterprise deployments.

Practical strategic priorities for vendors to align modular product design, supply resilience, and outcome-based services to secure adoption across research and clinical laboratory segments

Industry leaders should prioritize strategies that align product development, supply resilience, and customer-centric service models to capture the growing reliance on automated purification in both research and clinical settings. First, invest in modular platform design that supports multiple bead chemistries, variable deck configurations, and software-driven protocol libraries so that a single instrument can be validated across multiple use cases. This approach accelerates adoption among diverse end users and reduces total lifecycle training and validation costs for customers.

Second, strengthen supply chain resilience through diversified sourcing, regional manufacturing partnerships, and transparent spare-parts inventories. Such measures mitigate exposure to tariff-driven price volatility and shorten lead times for critical consumables. Third, expand service offerings to include outcome-oriented contracts that bundle preventive maintenance, consumable replenishment, and validation support; these commitments enhance customer confidence and reduce operational risk. Fourth, deepen collaborations with end users-academic centers, clinical labs, CROs, and pharma-to co-develop validated protocols for priority applications such as RNA sequencing, targeted sequencing, biomarker discovery, and diagnostic assays. These collaborations generate reference data, streamline regulatory submissions, and accelerate time-to-value for customers.

Finally, invest in training and digital support ecosystems that facilitate remote troubleshooting, protocol version control, and integration with laboratory information systems. By focusing on these strategic priorities, suppliers can convert technological capabilities into sustained operational advantage and become indispensable partners for laboratories navigating complex workflows and regulatory obligations.

A rigorous mixed-methods research approach combining primary interviews, technical literature review, and supply chain analysis to ensure actionable and validated insights for laboratory automation stakeholders

The research underpinning these insights combined primary interviews with laboratory directors, procurement leads, and automation engineers, alongside a structured review of recent technical literature and regulatory guidance relevant to nucleic acid and protein purification automation. Primary data collection focused on workflow preferences, validation pain points, and service expectations across a range of end users, from academic centers to commercial clinical laboratories. Interviews were selected to capture geographic diversity and different throughput profiles to ensure the findings reflect operational realities in centralized and decentralized testing environments.

Secondary research emphasized protocol adoption trends, advances in bead chemistries, and the evolution of liquid handling and magnetic module designs. Supply chain analysis incorporated publicly available trade and policy updates to assess potential impacts on component sourcing and regional manufacturing decisions. Where applicable, validation and regulatory guidance documents were reviewed to align product and service recommendations with current compliance expectations. Throughout the research, triangulation of multiple data sources was applied to ensure robustness, and findings were reviewed by subject-matter experts to validate technical accuracy and practical relevance.

Concluding synthesis on how automation, supply resilience, and collaborative validation define future adoption pathways and vendor differentiation in laboratory workflows

In summary, fully automatic magnetic bead purification systems are transitioning from specialized automation to foundational laboratory infrastructure that supports high-quality, reproducible molecular workflows. Technological refinements in bead chemistry, liquid handling fidelity, and software integration are expanding the range of compatible applications, while operational and regulatory pressures are driving demand for validated, auditable systems. At the same time, external forces such as tariff changes have highlighted the importance of supply chain resilience and transparent cost structures.

Segmentation by throughput, end user, and application clarifies why different laboratories prioritize distinct instrument attributes and service models. Regional dynamics further influence procurement and deployment strategies, with the Americas emphasizing integrated support, Europe, Middle East & Africa prioritizing regulatory and interoperability considerations, and Asia-Pacific balancing rapid capacity expansion with cost competitiveness. Competitive advantage accrues to vendors that pair modular technical platforms with comprehensive service and supply solutions, and that engage collaboratively with customers to co-develop validated workflows. Stakeholders who act on these insights will be better positioned to realize the efficiency, reliability, and scalability benefits that automated purification systems can deliver.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fully Automatic Magnetic Bead Purification System Market, by Throughput

  • 8.1. High Throughput
  • 8.2. Low Throughput
  • 8.3. Medium Throughput

9. Fully Automatic Magnetic Bead Purification System Market, by Application

  • 9.1. Diagnostic Testing
    • 9.1.1. Cancer Marker Detection
    • 9.1.2. Genetic Disorder Screening
    • 9.1.3. Infectious Disease Testing
  • 9.2. Drug Discovery
    • 9.2.1. Biomarker Discovery
    • 9.2.2. High-Throughput Screening
    • 9.2.3. Lead Identification
  • 9.3. Genomics
    • 9.3.1. RNA Sequencing
    • 9.3.2. Targeted Sequencing
    • 9.3.3. Whole Genome Sequencing
  • 9.4. Proteomics
    • 9.4.1. Mass Spectrometry
    • 9.4.2. Protein Arrays
    • 9.4.3. Western Blotting

10. Fully Automatic Magnetic Bead Purification System Market, by End User

  • 10.1. Academic And Research Institutes
  • 10.2. Clinical Diagnostics Laboratories
  • 10.3. Contract Research Organizations
  • 10.4. Pharma And Biotechnology Companies

11. Fully Automatic Magnetic Bead Purification System Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Fully Automatic Magnetic Bead Purification System Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Fully Automatic Magnetic Bead Purification System Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Fully Automatic Magnetic Bead Purification System Market

15. China Fully Automatic Magnetic Bead Purification System Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Agilent Technologies, Inc.
  • 16.6. Bio-Rad Laboratories, Inc.
  • 16.7. Danaher Corporation
  • 16.8. Hamilton Company
  • 16.9. MGI Tech Co., Ltd.
  • 16.10. Omega Bio-tek, Inc.
  • 16.11. PerkinElmer, Inc.
  • 16.12. Promega Corporation
  • 16.13. QIAGEN N.V.
  • 16.14. Roche Diagnostics International AG.
  • 16.15. Tecan Group AG
  • 16.16. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY HIGH THROUGHPUT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY HIGH THROUGHPUT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY HIGH THROUGHPUT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY LOW THROUGHPUT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY LOW THROUGHPUT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY LOW THROUGHPUT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY MEDIUM THROUGHPUT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY MEDIUM THROUGHPUT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY MEDIUM THROUGHPUT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CANCER MARKER DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CANCER MARKER DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CANCER MARKER DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENETIC DISORDER SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENETIC DISORDER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENETIC DISORDER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY LEAD IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY LEAD IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY LEAD IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEIN ARRAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEIN ARRAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEIN ARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY WESTERN BLOTTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY WESTERN BLOTTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PHARMA AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PHARMA AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PHARMA AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 154. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 156. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 157. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 158. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 159. GCC FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 178. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 180. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 181. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 182. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 183. G7 FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 186. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 188. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 189. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 190. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 191. NATO FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DIAGNOSTIC TESTING, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY GENOMICS, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY PROTEOMICS, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA FULLY AUTOMATIC MAGNETIC BEAD PURIFICATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)